Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 296 of 6351
-
New Drug-Free neck therapy shows promise for preeclampsia
Symptom relief Recruiting nowPreeclampsia is one of the most common and serious complications of pregnancy, affecting both the mother and baby. It is a condition characterized by high blood pressure and can lead to severe complications, including neurological issues and reduced blood flow to the placenta. Pr…
Sponsor: Fundación Internacional René Mey • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New probe technique could slash cervical cancer risk in HIV-Positive women
Prevention Not yet recruitingCervical cancer disproportionately affects women in low- and middle-income countries (LMICs), particularly women living with HIV (WLWH) who have a 6-fold increased risk of cervical cancer compared to women in the general population. Thermal ablation (TA) is recommended by the Wor…
Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Can a new antibiotic combo beat Drug-Resistant urinary infections in the blood?
Disease control Not yet recruitingThis study is designed to better understand how well a new antibiotic combination, cefepime/enmetazobactam (FEP/META), works in patients with complicated urinary tract infections that have spread to the bloodstream (bacteremia). These infections are caused by bacteria that are re…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Heated chemo offers new hope for bladder cancer patients facing surgery
Disease control Not yet recruitingThis is a Phase II, prospective, single-arm, open-label clinical study evaluating hyperthermic intravesical chemotherapy (HIVEC) with Mitomycin C in patients with high-grade, non-muscle-invasive bladder cancer (NMIBC) who are BCG-non-responsive or BCG-intolerant and are ineligibl…
Sponsor: AC.TA. S.r.l. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy aims to stop prostate cancer spread in high-risk patients
Disease control Recruiting nowThe advent of PSMA-PET has improved sensitivity and specificity in staging prostate cancer, particularly in intermediate- and high-risk disease. This has created uncertainty in the management of patients with PSMA-positive but conventionally negative pelvic lymphadenopathy (i.e.,…
Phase 2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can inhaled cell vesicles soothe damaged lungs in autoimmune disease?
Disease control Not yet recruitingImmune-mediated inflammatory diseases (IMIDs) are systemic inflammatory disorders driven by dysregulated immune responses that can affect multiple organs, including the lungs. Examples include Behçet disease, IgG4-related disease, and systemic sclerosis (SSc). IMID-related lung i…
Early phase 1 • Sponsor: Qiubai Li • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new drug ease the joint pain of psoriatic arthritis?
Disease control Not yet recruitingThe purpose of this Phase 2a/b study is: 1. to evaluate the efficacy, safety and tolerability of DDY391 in participants with psoriatic arthritis (PsA). 2. to determine the dose-response relationship of DDY391 in participants with PsA to support dose selection for Phase 3.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Targeted radiation after lung cancer surgery aims to stop return
Disease control Recruiting nowThis phase II trial compares the effect of intensity-modulated post-operative radiation therapy (I²-PORT) followed by standard of care therapy (chemotherapy or immunotherapy) to standard of care therapy alone in treating patients with non-small cell lung cancer (NSCLC) who have r…
Phase 2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New combo aims to wipe out hidden leukemia cells
Disease control Not yet recruitingThis phase II trial tests how well adding revumenib to usual treatment (blinatumomab) compared to usual treatment alone works in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) or acute leukemia with ambiguous lineage (ALAL) with KMT2A-translocation. Revumenib …
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
AI eye scans aim to predict Sight-Threatening complication after retinal surgery
Knowledge-focused By invitation onlyPatients with retinal detachment are at risk of recurrence and failure of surgery requiring multiple surgeries due to a condition called proliferative vitreoretinopathy (PVR). Study aims to help tailor patients' treatments and improve outcomes by: \[i\] studying imaging biomark…
Sponsor: University College, London • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Zapping the Brain's fear hub: a new hope for PTSD?
Disease control Not yet recruitingThe goal of this clinical trial is to learn how transcranial magnetic stimulation (TMS) affects brain circuits involving the amygdala in adults with posttraumatic stress disorder (PTSD). The main questions it aims to answer are: * Can MRI-guided TMS engage the amygdala by stimul…
Early phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can an inhaled drug tame RSV symptoms in adults?
Disease control Not yet recruitingA phase II clinical study to evaluate the efficacy and safety of YKYY018 for inhalation solution in adult participants with respiratory syncytial virus infection
Phase 2 • Sponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for older AML patients: gentler transplant approach aims to boost survival with less toxicity
Disease control Not yet recruitingAcute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS) predominantly affect older adults, and their incidence continues to rise with advanced age. For many patients, allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative optio…
Phase 2 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can watching and waiting beat early treatment for Slow-Growing head and neck tumors?
Disease control Not yet recruitingHead and neck paragangliomas (HNPGs) are predominantly non-secreting, benign and slow-growing tumors. Although most patients remain asymptomatic, up to 30% develop symptoms related to local tumor growth and fewer than 5-10% develop metastatic disease. Surgery has long been consid…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a new pill shorten the flu?
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase II study to evaluate the efficacy and safety of SYH2085 tablets compared with placebo in Chinese adult participants with uncomplicated influenza. The study plans to enroll patients with typical systemic and…
Phase 2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Blood pressure target during bypass surgery may cut complications
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether two approaches to anesthesia and blood pressure management can improve care for adults having off-pump coronary artery bypass grafting (OPCAB). OPCAB is a type of heart bypass surgery performed without routinely using a heart-lu…
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a new drug combo fight childhood brain tumors that Won't stop growing?
Disease control Not yet recruitingThis is a open label Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of escalating oral doses of NLG802, an investigational agent intended to inhibit the indoleamine 2,3-dioxygenase 1 (IDO1) enzyme, in combination with temozolomide chemotherapy in childre…
Phase 1 • Sponsor: Lumos Pharma • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
AI reads CT scans to predict lung cancer years before it starts
Diagnosis Not yet recruitingThis research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals.
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
Can a new daily pill offer lasting relief for anxiety?
Disease control Not yet recruitingThis is a global, Phase 3, multicenter, open-label extension trial designed to evaluate the long-term safety, tolerability and efficacy of SEP-363856 administered at doses of 50 milligrams (mg) or 75 mg per day in adult participants with generalized anxiety disorder (GAD) over a …
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can an eye injection slow a genetic cause of blindness?
Disease control Not yet recruitingThe purpose of this Phase 2 Open-label study is to evaluate the long-term safety and tolerability of Ultevursen administered via intravitreal injection (IVT) in participants with Retinitis Pigmentosa due to mutations in exon 13 of the USH2A gene. This is a multicenter study which…
Phase 2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC